Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 84

1.

Evidence for genetic contribution to the increased risk of type 2 diabetes in schizophrenia.

Hackinger S, Prins B, Mamakou V, Zengini E, Marouli E, Brčić L, Serafetinidis I, Lamnissou K, Kontaxakis V, Dedoussis G, Gonidakis F, Thanopoulou A, Tentolouris N, Tsezou A, Zeggini E.

Transl Psychiatry. 2018 Nov 23;8(1):252. doi: 10.1038/s41398-018-0304-6.

2.

Expression of Nedd9 in Transbronchial Biopsies of Lung Adenocarcinoma.

Ostojić J, Brčić L, Hrabač P, Seiwerth S.

Acta Clin Croat. 2018 Jun;57(2):251-256. doi: 10.20471/acc.2018.57.02.04.

PMID:
30431717
3.

In Reply.

Brcic L, Vlacic G, Quehenberger F, Kern I.

Arch Pathol Lab Med. 2018 Nov;142(11):1311-1312. doi: 10.5858/arpa.2018-0196-LE. No abstract available.

PMID:
30407857
4.

Thyroglobulin Antibodies are Associated with Symptom Burden in Patients with Hashimoto's Thyroiditis: A Cross-Sectional Study.

Barić A, Brčić L, Gračan S, Škrabić V, Brekalo M, Šimunac M, Lovrić VT, Anić I, Barbalić M, Zemunik T, Punda A, Boraska Perica V.

Immunol Invest. 2018 Oct 17:1-12. doi: 10.1080/08820139.2018.1529040. [Epub ahead of print]

PMID:
30332318
5.

Genome-wide association analysis suggests novel loci for Hashimoto's thyroiditis.

Brčić L, Barić A, Gračan S, Brekalo M, Kaličanin D, Gunjača I, Torlak Lovrić V, Tokić S, Radman M, Škrabić V, Miljković A, Kolčić I, Štefanić M, Glavaš-Obrovac L, Lessel D, Polašek O, Zemunik T, Barbalić M, Punda A, Boraska Perica V.

J Endocrinol Invest. 2018 Oct 3. doi: 10.1007/s40618-018-0955-4. [Epub ahead of print]

PMID:
30284222
6.

Evaluation of Correlations Between Food-Specific Antibodies and Clinical Aspects of Hashimoto's Thyroiditis.

Kaličanin D, Brčić L, Barić A, Zlodre S, Barbalić M, Torlak Lovrić V, Punda A, Boraska Perica V.

J Am Coll Nutr. 2018 Sep 28:1-8. doi: 10.1080/07315724.2018.1503103. [Epub ahead of print]

PMID:
30265836
7.

PD-1 and PD-L1 Protein Expression Predict Survival in Completely Resected Lung Adenocarcinoma.

Zaric B, Brcic L, Buder A, Brandstetter A, Buresch JO, Traint S, Kovacevic T, Stojsic V, Perin B, Pirker R, Filipits M.

Clin Lung Cancer. 2018 Nov;19(6):e957-e963. doi: 10.1016/j.cllc.2018.08.014. Epub 2018 Aug 22.

PMID:
30197262
8.

Candida infection of membrane oxygenator during ECMO therapy.

Schilcher G, Eisner F, Hackl G, Eller P, Valentin T, Zollner-Schwetz I, Krause R, Brcic L.

J Infect. 2018 Aug 24. pii: S0163-4453(18)30256-1. doi: 10.1016/j.jinf.2018.08.011. [Epub ahead of print] No abstract available.

PMID:
30149029
9.

Influence of eukaryotic translation initiation factor 6 on non-small cell lung cancer development and progression.

Gantenbein N, Bernhart E, Anders I, Golob-Schwarzl N, Krassnig S, Wodlej C, Brcic L, Lindenmann J, Fink-Neuboeck N, Gollowitsch F, Stacher-Priehse E, Asslaber M, Gogg-Kamerer M, Rolff J, Hoffmann J, Silvestri A, Regenbrecht C, Reinhard C, Pehserl AM, Pichler M, Sokolova O, Naumann M, Mitterer V, Pertschy B, Bergler H, Popper H, Sattler W, Haybaeck J.

Eur J Cancer. 2018 Sep;101:165-180. doi: 10.1016/j.ejca.2018.07.001. Epub 2018 Aug 1.

10.

Non-Small Cell Lung Cancer in Countries of Central and Southeastern Europe: Diagnostic Procedures and Treatment Reimbursement Surveyed by the Central European Cooperative Oncology Group.

Ryska A, Buiga R, Fakirova A, Kern I, Olszewski W, Plank L, Seiwerth S, Toth E, Zivka E, Thallinger C, Zielinski C, Brcic L.

Oncologist. 2018 Aug 3. pii: theoncologist.2018-0008. doi: 10.1634/theoncologist.2018-0008. [Epub ahead of print]

PMID:
30076278
11.

Bulk tumour cell migration in lung carcinomas might be more common than epithelial-mesenchymal transition and be differently regulated.

Zacharias M, Brcic L, Eidenhammer S, Popper H.

BMC Cancer. 2018 Jul 6;18(1):717. doi: 10.1186/s12885-018-4640-y.

12.

Microsatellite instability in metaplasia-dysplasia-adenocarcinoma sequence of Barrett esophagus: a retrospective study.

Markoš P, Brčić I, Brčić L, Jakić-Razumović J, Pulanić R.

Croat Med J. 2018 Jun 30;59(3):100-107.

13.

Afatinib restrains K-RAS-driven lung tumorigenesis.

Moll HP, Pranz K, Musteanu M, Grabner B, Hruschka N, Mohrherr J, Aigner P, Stiedl P, Brcic L, Laszlo V, Schramek D, Moriggl R, Eferl R, Moldvay J, Dezso K, Lopez-Casas PP, Stoiber D, Hidalgo M, Penninger J, Sibilia M, Győrffy B, Barbacid M, Dome B, Popper H, Casanova E.

Sci Transl Med. 2018 Jun 20;10(446). pii: eaao2301. doi: 10.1126/scitranslmed.aao2301.

PMID:
29925635
14.

Expression of plakophilin 3 in diffuse malignant pleural mesothelioma.

Mašić S, Brčić L, Krušlin B, Šepac A, Pigac B, Stančić-Rokotov D, Jakopović M, Seiwerth S.

Histol Histopathol. 2018 Sep;33(9):995-1004. doi: 10.14670/HH-11-996. Epub 2018 May 3.

PMID:
29722422
15.

FGF2 and EGF induce epithelial-mesenchymal transition in malignant pleural mesothelioma cells via a MAPKinase/MMP1 signal.

Schelch K, Wagner C, Hager S, Pirker C, Siess K, Lang E, Lin R, Kirschner MB, Mohr T, Brcic L, Marian B, Holzmann K, Grasl-Kraupp B, Krupitza G, Laszlo V, Klikovits T, Dome B, Hegedus B, Garay T, Reid G, van Zandwijk N, Klepetko W, Berger W, Grusch M, Hoda MA.

Carcinogenesis. 2018 Apr 5;39(4):534-545. doi: 10.1093/carcin/bgy018.

PMID:
29635378
16.

Assessment of tumor margins in head and neck cancer using a 3D-navigation system based on PET/CT image-fusion - A pilot study.

Zrnc TA, Wallner J, Zemann W, Pau M, Gstettner C, Brcic L, Assaf AT, Hassanzadeh H, Feichtinger M, Schwenzer-Zimmerer K.

J Craniomaxillofac Surg. 2018 Apr;46(4):617-623. doi: 10.1016/j.jcms.2018.01.011. Epub 2018 Feb 19.

PMID:
29526413
17.

NSCLC molecular testing in Central and Eastern European countries.

Ryska A, Berzinec P, Brcic L, Cufer T, Dziadziuszko R, Gottfried M, Kovalszky I, Olszewski W, Oz B, Plank L, Timar J.

BMC Cancer. 2018 Mar 9;18(1):269. doi: 10.1186/s12885-018-4023-4.

18.

Immune cell landscape in therapy-naïve squamous cell and adenocarcinomas of the lung.

Brcic L, Stanzer S, Krenbek D, Gruber-Moesenbacher U, Absenger G, Quehenberger F, Valipour A, Lindenmann J, Stoeger H, Al Effah M, Fediuk M, Balic M, Popper HH.

Virchows Arch. 2018 Apr;472(4):589-598. doi: 10.1007/s00428-018-2326-0. Epub 2018 Mar 8.

19.

Reproducibility of Malignant Pleural Mesothelioma Histopathologic Subtyping.

Brcic L, Vlacic G, Quehenberger F, Kern I.

Arch Pathol Lab Med. 2018 Jun;142(6):747-752. doi: 10.5858/arpa.2017-0295-OA. Epub 2018 Mar 6.

PMID:
29509030
20.

Non-sebaceous lymphadenoma of the lacrimal gland: first report of a new localization.

Pau M, Brcic L, Seethala RR, Klein-Theyer AK, Magyar M, Reinbacher KE, Schweiger M, Wallner J, Jakse N.

Virchows Arch. 2018 Jul;473(1):127-130. doi: 10.1007/s00428-018-2322-4. Epub 2018 Feb 19. No abstract available.

PMID:
29460186
21.

Nuclear grade and necrosis predict prognosis in malignant epithelioid pleural mesothelioma: a multi-institutional study.

Rosen LE, Karrison T, Ananthanarayanan V, Gallan AJ, Adusumilli PS, Alchami FS, Attanoos R, Brcic L, Butnor KJ, Galateau-Sallé F, Hiroshima K, Kadota K, Klampatsa A, Stang NL, Lindenmann J, Litzky LA, Marchevsky A, Medeiros F, Montero MA, Moore DA, Nabeshima K, Pavlisko EN, Roggli VL, Sauter JL, Sharma A, Sheaff M, Travis WD, Vigneswaran WT, Vrugt B, Walts AE, Tjota MY, Krausz T, Husain AN.

Mod Pathol. 2018 Apr;31(4):598-606. doi: 10.1038/modpathol.2017.170. Epub 2018 Jan 12.

PMID:
29327706
22.

Frequency and clinical impact of preoperative circulating tumor cells in resectable non-metastatic lung adenocarcinomas.

Dandachi N, Tiran V, Lindenmann J, Brcic L, Fink-Neuboeck N, Kashofer K, Absenger G, Bezan A, Cote RJ, Datar R, Balic M.

Lung Cancer. 2017 Nov;113:152-157. doi: 10.1016/j.lungcan.2017.10.003. Epub 2017 Oct 9.

PMID:
29110843
23.

Primary patient-derived lung adenocarcinoma cell culture challenges the association of cancer stem cells with epithelial-to-mesenchymal transition.

Tiran V, Lindenmann J, Brcic L, Heitzer E, Stanzer S, Tabrizi-Wizsy NG, Stacher E, Stoeger H, Popper HH, Balic M, Dandachi N.

Sci Rep. 2017 Aug 30;7(1):10040. doi: 10.1038/s41598-017-09929-0.

24.

Association of Established Thyroid-stimulating Hormone and Free Thyroxine Genetic Variants with Hashimoto's Thyroiditis.

Brčić L, Gračan S, Barić A, Gunjača I, Torlak Lovrić V, Kolčić I, Zemunik T, Polašek O, Barbalić M, Punda A, Boraska Perica V.

Immunol Invest. 2017 Aug;46(6):625-638. doi: 10.1080/08820139.2017.1337785.

PMID:
28753406
25.

Is macrocytosis a potential biomarker of the efficacy of dose-dense paclitaxel-carboplatin combination therapy in patients with epithelial ovarian cancer?

Boraska Jelavić T, Boban T, Brčić L, Vrdoljak E.

Anticancer Drugs. 2017 Sep;28(8):922-927. doi: 10.1097/CAD.0000000000000538.

PMID:
28678030
26.

Pulmonary granular cell tumours: case presentations and literature review.

Radić P, Brčić L.

Scott Med J. 2017 May;62(2):70-73. doi: 10.1177/0036933017711796. Epub 2017 May 23. Review.

PMID:
28534663
27.

Association of established hypothyroidism-associated genetic variants with Hashimoto's thyroiditis.

Barić A, Brčić L, Gračan S, Torlak Lovrić V, Gunjača I, Šimunac M, Brekalo M, Boban M, Polašek O, Barbalić M, Zemunik T, Punda A, Boraska Perica V.

J Endocrinol Invest. 2017 Oct;40(10):1061-1067. doi: 10.1007/s40618-017-0660-8. Epub 2017 Apr 5.

PMID:
28382505
28.

Meprin β contributes to collagen deposition in lung fibrosis.

Biasin V, Wygrecka M, Marsh LM, Becker-Pauly C, Brcic L, Ghanim B, Klepetko W, Olschewski A, Kwapiszewska G.

Sci Rep. 2017 Jan 6;7:39969. doi: 10.1038/srep39969.

29.

Analysis of the frequency of EGFR, KRAS and ALK mutations in patients with lung adenocarcinoma in Croatia.

Brcic L, Jakopovic M, Misic M, Seiwerth F, Kern I, Smojver-Jezek S, Quehenberger F, Samarzija M, Seiwerth S.

Diagn Pathol. 2016 Sep 21;11(1):90.

30.

[Neuroendocrine neoplasms of the mediastinum].

Brcic L, Heidinger M, Popper H.

Pathologe. 2016 Sep;37(5):434-40. doi: 10.1007/s00292-016-0198-0. Review. German.

PMID:
27507161
31.

Circulating activin A is a novel prognostic biomarker in malignant pleural mesothelioma - A multi-institutional study.

Hoda MA, Dong Y, Rozsas A, Klikovits T, Laszlo V, Ghanim B, Stockhammer P, Ozsvar J, Jakopovic M, Samarzija M, Brcic L, Bendek M, Szirtes I, Reid G, Kirschner MB, Kao SC, Opitz I, Weder W, Frauenfelder T, Nguyen-Kim TD, Aigner C, Klepetko W, van Zandwijk N, Berger W, Dome B, Grusch M, Hegedus B.

Eur J Cancer. 2016 Aug;63:64-73. doi: 10.1016/j.ejca.2016.04.018. Epub 2016 Jun 8.

PMID:
27288871
32.

Association of established thyroid peroxidase autoantibody (TPOAb) genetic variants with Hashimoto's thyroiditis.

Brčić L, Barić A, Gračan S, Brdar D, Torlak Lovrić V, Vidan N, Zemunik T, Polašek O, Barbalić M, Punda A, Boraska Perica V.

Autoimmunity. 2016 Nov;49(7):480-485. Epub 2016 Jun 7.

PMID:
27268232
33.

SUCCESSFUL TREATMENT OF PULMONARY AND LYMPHATIC MANIFESTATIONS OF LYMPHANGIOLEIOMYOMATOSIS WITH SIROLIMUS.

Hecimovic A, Jakopovic M, Pavlisa G, Jankovic M, Vukic-Dugac A, Redzepi G, Brcic L, Samarzija M, Gupta N.

Lymphology. 2015 Jun;48(2):97-102.

PMID:
26714374
34.

Acquiring experience in pathology predominantly from what you see, not from what you read: the HIPON e-learning platform.

Riccioni O, Vrasidas C, Brcic L, Armenski G, Seiwerth S, Smeets A, van Krieken JH, Lazaris AC.

Adv Med Educ Pract. 2015 Jun 8;6:439-45. doi: 10.2147/AMEP.S79182. eCollection 2015.

35.

Solitary pulmonary amyloidoma mimicking lung cancer on 18F-FDG PET-CT scan in systemic lupus erythematosus patient.

Barešić M, Sreter KB, Brčić L, Hećimović A, Janevski Z, Anić B.

Lupus. 2015 Dec;24(14):1546-51. doi: 10.1177/0961203315591025. Epub 2015 Jun 17.

PMID:
26085598
36.

Epigenetic down-regulation of integrin α7 increases migratory potential and confers poor prognosis in malignant pleural mesothelioma.

Laszlo V, Hoda MA, Garay T, Pirker C, Ghanim B, Klikovits T, Dong YW, Rozsas A, Kenessey I, Szirtes I, Grusch M, Jakopovic M, Samarzija M, Brcic L, Kern I, Rozman A, Popper H, Zöchbauer-Müller S, Heller G, Altenberger C, Ziegler B, Klepetko W, Berger W, Dome B, Hegedus B.

J Pathol. 2015 Oct;237(2):203-14. doi: 10.1002/path.4567. Epub 2015 Jul 14.

PMID:
26011651
37.

Perforating corneal injury in rat and pentadecapeptide BPC 157.

Masnec S, Kokot A, Zlatar M, Kalauz M, Kunjko K, Radic B, Klicek R, Drmic D, Lazic R, Brcic L, Radic R, Ivekovic R, Seiwerth S, Sikiric P.

Exp Eye Res. 2015 Jul;136:9-15. doi: 10.1016/j.exer.2015.04.016. Epub 2015 Apr 24.

PMID:
25912999
38.
39.

Ki67 index is an independent prognostic factor in epithelioid but not in non-epithelioid malignant pleural mesothelioma: a multicenter study.

Ghanim B, Klikovits T, Hoda MA, Lang G, Szirtes I, Setinek U, Rozsas A, Renyi-Vamos F, Laszlo V, Grusch M, Filipits M, Scheed A, Jakopovic M, Samarzija M, Brcic L, Stancic-Rokotov D, Kern I, Rozman A, Dekan G, Klepetko W, Berger W, Glasz T, Dome B, Hegedus B.

Br J Cancer. 2015 Mar 3;112(5):783-92. doi: 10.1038/bjc.2015.9. Epub 2015 Jan 29.

40.

Reproducibility of histological subtyping of malignant pleural mesothelioma.

Brčić L, Jakopović M, Brčić I, Klarić V, Milošević M, Sepac A, Samaržija M, Seiwerth S.

Virchows Arch. 2014 Dec;465(6):679-85. doi: 10.1007/s00428-014-1664-9. Epub 2014 Oct 10.

PMID:
25300229
41.

Intraparenchymal pulmonary lipoma clinically mimicking malignant neoplasm.

Bacalja J, Nikolić I, Brčić L.

Arch Bronconeumol. 2015 Jun;51(6):302-3. doi: 10.1016/j.arbres.2014.06.021. Epub 2014 Oct 1. English, Spanish. No abstract available.

42.

Pentadecapeptide BPC 157 and anaphylactoid reaction in rats and mice after intravenous dextran and white egg administration.

Duplancic B, Stambolija V, Holjevac J, Zemba M, Balenovic I, Drmic D, Suran J, Radic B, Filipovic M, Blagaic AB, Brcic L, Kolenc D, Grabarevic Z, Seiwerth S, Sikiric P.

Eur J Pharmacol. 2014 Mar 15;727:75-9. doi: 10.1016/j.ejphar.2014.01.046. Epub 2014 Jan 31.

PMID:
24486708
43.

Circulating fibrinogen is a prognostic and predictive biomarker in malignant pleural mesothelioma.

Ghanim B, Hoda MA, Klikovits T, Winter MP, Alimohammadi A, Grusch M, Dome B, Arns M, Schenk P, Jakopovic M, Samarzija M, Brcic L, Filipits M, Laszlo V, Klepetko W, Berger W, Hegedus B.

Br J Cancer. 2014 Feb 18;110(4):984-90. doi: 10.1038/bjc.2013.815. Epub 2014 Jan 16.

44.

Stable gastric pentadecapeptide BPC 157 heals cysteamine-colitis and colon-colon-anastomosis and counteracts cuprizone brain injuries and motor disability.

Klicek R, Kolenc D, Suran J, Drmic D, Brcic L, Aralica G, Sever M, Holjevac J, Radic B, Turudic T, Kokot A, Patrlj L, Rucman R, Seiwerth S, Sikiric P.

J Physiol Pharmacol. 2013 Oct;64(5):597-612.

45.

BPC 157 and blood vessels.

Seiwerth S, Brcic L, Vuletic LB, Kolenc D, Aralica G, Misic M, Zenko A, Drmic D, Rucman R, Sikiric P.

Curr Pharm Des. 2014;20(7):1121-5. Review.

PMID:
23782145
46.

Stable gastric pentadecapeptide BPC 157-NO-system relation.

Sikiric P, Seiwerth S, Rucman R, Turkovic B, Rokotov DS, Brcic L, Sever M, Klicek R, Radic B, Drmic D, Ilic S, Kolenc D, Aralica G, Stupnisek M, Suran J, Barisic I, Dzidic S, Vrcic H, Sebecic B.

Curr Pharm Des. 2014;20(7):1126-35. Review.

PMID:
23755725
47.

Salutary effect of gastric pentadecapeptide BPC 157 in two different stress urinary incontinence models in female rats.

Jandric I, Vrcic H, Jandric Balen M, Kolenc D, Brcic L, Radic B, Drmic D, Seiwerth S, Sikiric P.

Med Sci Monit Basic Res. 2013 Mar 12;19:93-102. doi: 10.12659/MSMBR.883828.

48.

Pentadecapeptide BPC 157 and the esophagocutaneous fistula healing therapy.

Cesarec V, Becejac T, Misic M, Djakovic Z, Olujic D, Drmic D, Brcic L, Rokotov DS, Seiwerth S, Sikiric P.

Eur J Pharmacol. 2013 Feb 15;701(1-3):203-12. doi: 10.1016/j.ejphar.2012.11.055. Epub 2012 Dec 7.

PMID:
23220707
49.

Morphologic and clinicopathologic features of lung squamous cell carcinomas expressing Sox2.

Brcic L, Sherer CK, Shuai Y, Hornick JL, Chirieac LR, Dacic S.

Am J Clin Pathol. 2012 Nov;138(5):712-8. doi: 10.1309/AJCP05TTWQTWNLTN.

PMID:
23086772
50.

Toxicity by NSAIDs. Counteraction by stable gastric pentadecapeptide BPC 157.

Sikiric P, Seiwerth S, Rucman R, Turkovic B, Rokotov DS, Brcic L, Sever M, Klicek R, Radic B, Drmic D, Ilic S, Kolenc D, Aralica G, Safic H, Suran J, Rak D, Dzidic S, Vrcic H, Sebecic B.

Curr Pharm Des. 2013;19(1):76-83. Review.

PMID:
22950504

Supplemental Content

Support Center